InfuSystem Holdings (INFU) Capital Expenditures Growth (3y) (2013 - 2026)
InfuSystem Holdings (INFU) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 2.15% |
| 10 | InfuSystem Holdings | 190.39 Mn | 188.28 Mn | 19.68 Mn | -20.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.88% |
| Dec 31, 2025 | 26.07% |
| Sep 30, 2025 | -47.69% |
| Jun 30, 2025 | 270.73% |
| Mar 31, 2025 | -170.45% |
| Dec 31, 2024 | -43.08% |
| Sep 30, 2024 | -92.54% |
| Jun 30, 2024 | 44.93% |
| Mar 31, 2024 | -125.06% |
| Dec 31, 2023 | -212.58% |
| Sep 30, 2023 | 73.22% |
| Jun 30, 2023 | 5.44% |
| Mar 31, 2023 | -15.69% |
| Dec 31, 2022 | -20.00% |
| Sep 30, 2022 | 170.14% |
| Jun 30, 2022 | 81.06% |
| Mar 31, 2022 | -77.36% |
| Dec 31, 2021 | 30.20% |
| Sep 30, 2021 | -28.67% |
| Jun 30, 2021 | -43.42% |